KRAS ligand 4
KRAS ligand 4 (compound 2) is a bifunctional degrader based on SOS1. KRAS ligand 4 reduces downstream signaling markers pERK and pS6 and displays anti-additional activity in cells with multiple KRAS mutations.
For research use only. We do not sell to patients.
- Formula: C24H28ClF3N6O3
- Molecular Weight:540.97
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
SOS1, or SOS1 guanine nucleotide exchange factor, is a key positive regulator of the RAS signaling pathway. It catalyzes the release of GDP from RAS proteins and the binding of GTP, thereby activating RAS. SOS1 expression is aberrant in various KRAS-mutant cancers, making it an important target for developing drugs targeting the KRAS pathway. pERK/pS6 refers to phosphorylated ERK and phosphorylated S6 ribosomal proteins, downstream phosphorylation markers of the MAPK/ERK and mTOR signaling pathways, respectively. Changes in their levels are commonly used to assess the activation status of intracellular RAS/MAPK and PI3K/mTOR signaling pathways and the effects of drug targets.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Molecular Weight 540.97
-
Formula C24H28ClF3N6O3
-
SMILES
FC(F)(F)C1=CC([C@@H](C)NC2=NC(Cl)=NC3=C2CN(C(C4(OC)CCN(C(C)=O)CC4)=O)C3)=CC(N)=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)